Reata Pharmaceuticals Inc (NASDAQ:RETA)

26.87
Delayed Data
As of 3:59pm ET
 -0.20 / -0.74%
Today’s Change
20.24
Today|||52-Week Range
153.41
+1.90%
Year-to-Date

Stock Price Forecast

The 9 analysts offering 12-month price forecasts for Reata Pharmaceuticals Inc have a median target of 67.00, with a high estimate of 75.00 and a low estimate of 35.00. The median estimate represents a +149.35% increase from the last price of 26.87.

Analyst Recommendations

The current consensus among 9 polled investment analysts is to Buy stock in Reata Pharmaceuticals Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$2.10
Sales
$1.5M
Reporting Date
Aug 10

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -3.39%
 
 
 
 
 
 
Growthannually -3.70%
 
 
 
 
 
 

Sales

Growthquarterly 60.00%
 
 
 
 
 
 
Growthannually -62.96%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.